Tumor Hypoxia With HX4 PET in Several Diseases

NCT02584400 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped patients did not want to participate

Conditions

Prostatic Neoplasms
Esophageal Neoplasms
Neoplasm Metastases, Brain
Rectal Neoplasms
Brain Neoplasm, Primary

Interventions

DRUG: Injection with the hypoxia tracer [18F]HX4,

Sponsor

Maastricht Radiation Oncology